Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System

De -
Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute
Migraine and Cluster Headache: First Product Featuring Novel DosePro
Needle-Free Delivery System
July 16, 2009
SAN DIEGO, July 16 /PRNewswire/ -- Zogenix, Inc., a privately held
pharmaceutical company, today announced that it has received approval
from the U.S. Food and Drug Administration (FDA) for its New Drug
Application (NDA) for Sumavel DosePro (sumatriptan injection)
needle-free delivery system to treat acute migraine, with or without
aura, and cluster headache. Sumavel DosePro is a first-of-its-kind
needle-free delivery system for subcutaneous sumatriptan, a treatment
that provides migraine relief within 10 minutes for some patients.

Comentarios

Publicar un comentario

Entradas populares de este blog

cómo diseñar un hospital veterinario by @esgdm

De -
Imagen
Diseñar un hospital de animales significa comprometer entre lo práctico y lo profético. Es fácil criticar los primeros planos de planta u hospitales más antiguos, pero ¿cómo podrían estos arquitectos haber previsto futuras opciones de tratamiento y servicio? Los hospitales veterinarios están diseñados para atender la tecnología médica, y la tecnología evoluciona constantemente. Aunque no podemos predecir todo el equipo y las características que ofrecerán los futuros hospitales, esta lista proporciona un punto de partida. Ya sea que esté planeando construir o remodelar, considere estos elementos: Aparcamiento Señalización Iluminación de seguridad y protección. Reliefarea para mascotas Cámara de seguridad Entrada del edificio Escape de aire / animal Superficies antideslizantes Área de recepción Caja registradora Computadora Teléfono / sistema de intercomunicación Sistema de tarjetas de crédito Bloqueo de cajones Diseño de mostrador ergonómico. TV
Leer más

BD Unveils Nano Pen Needle for Accurate Subcutaneous Insulin Injections

De -
Imagen
BD is releasing its new Nano pen needle designed for achieving consistent depth during subcutaneous injections, particularly for diabetic patients on insulin. Intramuscular injections can occur when a patient applies too much force to many of the existing injection devices. The new BD Nano compensates for this by spreading the load across the injection site and preventing the needle from going to far under the surface of the skin. In a study, this design helped to achieve more reliable injections which led to an 8-fold decrease in “calculated intramuscular injection risk,” according to BD. “The launch of BD Nano 2nd gen pen needles reinforces BD’s commitment to providing the most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use,” said Stanislav Glezer, MD, MBA, global vice president of Medical Affairs for BD, a press release. “In addition to the added clinical benefits the latest BD innovation brings, the new ergono
Leer más